Core Insights - The high-end medical equipment industry is currently experiencing a "resonance period" of policy dividends and technological iteration, with accelerated approval for innovative devices and expanded insurance coverage [1][9] - Raytai Medical is leveraging its precision technology in tumor radiotherapy to enter the medical aesthetics market, focusing on scar removal and other applications, while also pursuing overseas markets through a "technology output + localized cooperation" model [1][7] Industry Challenges - The high-end radiotherapy equipment market has been dominated by a few international giants, leading to high costs and significant barriers to entry for new players [3][8] - The industry faces challenges such as narrow specialization, high investment, and long return cycles, making it difficult for companies to innovate or replicate existing technologies [3] Technological Innovations - Raytai Medical has developed a globally innovative "dual-layer staggered grating system" that allows for three-dimensional shielding, enhancing precision in treating irregular tumors [3][4] - The company's latest SuperX robotic radiotherapy system integrates robotic technology for real-time tracking of moving targets, achieving millimeter-level accuracy and a response time of 0.5 seconds [4][5] Market Expansion Strategies - Raytai Medical is extending its technology into new markets, such as medical aesthetics, by developing smaller, mobile robotic systems that maintain high precision [5][6] - The company is focusing on international expansion through partnerships with local entities in countries along the "Belt and Road" initiative, allowing for localized production and market penetration [7][9] Future Directions - Raytai Medical is exploring the application of its precision radiotherapy technology in other medical fields, such as cardiology and rheumatology, aiming for breakthroughs in non-invasive treatments [6][8] - The company emphasizes the importance of mastering original core technologies to break the reliance on imported standards and to establish a comprehensive system from equipment to clinical solutions [8][9]